Protocol No
MODERNA-MRNA-2808-P101
Staff Member
Binod Dhakal
Phase
I/II
Summary
This project is being done to learn more about an investigational drug called mRNA-2808.
Objective
A Phase 1 2 Study of mRNA-2808 in Patients with Relapsed or Refractory Multiple Myeloma
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov